Immunic Inc. (IMUX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Immunic Inc.

    NASDAQ: IMUX · Real-Time Price · USD
    0.76
    -0.01 (-1.30%)
    At close: Sep 05, 2025, 3:59 PM
    0.76
    -0.13%
    After-hours: Sep 05, 2025, 07:56 PM EDT

    Immunic Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 134K 111K 77K 85K
    Gross Profit
    		 -134K -111K -77K -85K
    Operating Income
    		 -98.05M -99.22M -119.49M -91.67M
    Interest Income
    		 3.39M 3.08M 1.04M 66K
    Pretax Income
    		 -100.51M -93.61M -120.41M -92.94M
    Net Income
    		 -100.51M -93.61M -120.41M -92.79M
    Selling & General & Admin
    		 18.01M 16.01M 15.26M 13.3M
    Research & Development
    		 80.05M 83.22M 71.25M 61.12M
    Other Expenses
    		 n/a n/a n/a 17.25M
    Operating Expenses
    		 98.05M 99.22M 86.52M 91.67M
    Interest Expense
    		 n/a n/a 1.04M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 98.05M 99.22M 86.52M 91.67M
    Income Tax Expense
    		 n/a n/a 33.89M -151K
    Shares Outstanding (Basic)
    		 100.17M 44.32M 31.82M 23.65M
    Shares Outstanding (Diluted)
    		 100.17M 44.32M 31.82M 23.65M
    EPS (Basic)
    		 -1 -2.11 -3.78 -3.92
    EPS (Diluted)
    		 -1 -2.11 -3.78 -3.92
    EBITDA
    		 -100.37M -99.11M -120.33M -92.86M
    EBIT
    		 -100.51M -99.22M -120.41M -92.94M
    Depreciation & Amortization
    		 134K 111K 77K 85K

    Add to Watchlist